About Biolife Technologies Private Limited
Data last updated: 18 December 2025
Biolife Technologies Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in industrial chemicals, a part of the broader chemicals and materials sector. Incorporated on 28 July 2000, the company has been in operation for over 26 years.
Registered with ROC Hyderabad under CIN U73100TG2000PLC035011.
Capital: an authorised share capital of ₹80 Lakh and a paid-up capital of ₹50 Lakh. Formerly known as Biolife Technologies Limited. It is led by directors Rishi Gaggar and Shiven Gaggar.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Plot No: 165 & 166/P Ida Jeedimetla, Hyderabad, Telangana, India – 500055.
The company is associated with 1 brand - Biolife Technologies. As per MCA filings, the company has satisfied charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biolifeherbals.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressPlot No: 165 & 166/P Ida Jeedimetla, Hyderabad, Telangana, India – 500055
-
IndustryChemicals and Materials, Industrial Chemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Biolife Technologies Private Limited
Biolife Technologies Private Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U73100TG2000PTC035011, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG2000PTC035011 | Current |
| U73100TG2000PLC035011 | Previous |
| U73100AP2000PLC035011 | Previous |
Associated Brands with Biolife Technologies Private Limited
Biolife Technologies Private Limited operates one associated brand: Biolife Technologies. These brands represent Biolife Technologies Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures Ayurvedic products including baby care, hair care, and edible oils for worldwide distribution. | biolifeherbals.com |
Competitors & Alternatives of Biolife Technologies Private Limited
Brands and companies operating in the same space as Biolife Technologies Private Limited include Mamaearth, The Body Shop India, Dabur and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Mamaearth
|
Online brand offering multi-category natural skin care and makeup products | Gurugram, India, India | 2016 |
The Body Shop India
|
Cruelty-free beauty and body care products are retailed in India. | Gurugram, India, India | 2006 |
Dabur
|
Manufacturer of ayurvedic medicine and natural consumer products | Delhi, India, India | 1884 |
WOW Skin Science
|
Organic beauty products are offered by an internet-first brand. | Bengaluru, India, India | 2014 |
Brillare
|
Multi-category natural beauty products are offered online by Brillare. | Ahmedabad, India, India | 2009 |
Juicy Chemistry
|
Natural skin and hair care products are sold online. | Coimbatore, India, India | 2014 |
Pureplay Skin Sciences
|
Online platform offering beauty & personal care products | Thane, India, India | 2013 |
St.Botanica
|
Organic beauty products are offered by this internet-first brand. | Panchkula, India, India | 2007 |
Board of Directors of Biolife Technologies Private Limited
Biolife Technologies Private Limited is currently managed by 2 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishi Gaggar | Director | 30 Sep 2015 | 10 Years 9 Months | Current |
| Shiven Gaggar | Director | 30 Sep 2015 | 10 Years 9 Months | Current |
Financials of Biolife Technologies Private Limited FY 2024 filings available
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Biolife Technologies Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2003 | Andhra Bank | ₹10 Lakh | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Biolife Technologies Private Limited
View historical data on people associated with Biolife Technologies Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Biolife Technologies Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Biolife Technologies Private Limited
GSTIN & GST Filing Data of Biolife Technologies Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Biolife Technologies Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Biolife Technologies Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Biolife Technologies Private Limited
MSME Payment Delays by Biolife Technologies Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Biolife Technologies Private Limited
Subsidiaries & Group Companies of Biolife Technologies Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Biolife Technologies Private Limited with ownership details.
MCA Filings & Documents of Biolife Technologies Private Limited
MCA Filings & Documents of Biolife Technologies Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Biolife Technologies Private Limited
Frequently Asked Questions about Biolife Technologies Private Limited
Biolife Technologies Private Limited is an active private limited company in the chemicals and materials sector based in Hyderabad, Telangana, India. It was incorporated on 28 July 2000 (26+ years old) and is registered under CIN U73100TG2000PTC035011.
The current directors of Biolife Technologies Private Limited are:
The primary industry of Biolife Technologies Private Limited is chemicals and materials. The company specifically operates in industrial chemicals. The company is currently active in this sector.
Biolife Technologies Private Limited can be reached at the registered office: Plot No: 165 & 166P Ida Jeedimetla, Hyderabad, Telangana, India – 500055, or through the website biolifeherbals.com.
The authorised capital is ₹80 Lakh, and the paid-up capital is ₹50 Lakh.
The company has its registered office at Plot No: 165 & 166P Ida Jeedimetla, Hyderabad, Telangana, India – 500055.